AURKA Is a Prognostic Potential Therapeutic Target in Skin Cutaneous Melanoma Modulating the Tumor Microenvironment, Apoptosis, and Hypoxia

Scientists reported that the small-molecule compound ZNC97018978 targeting Aurora Kinase A (AURKA) screened by molecular docking technology can inhibit the proliferation, invasion and metastasis of skin cutaneous melanoma (SKCM).